LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
16447-5 | Cocaine | ACnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Cocaine [Units/volume] in Serum or Plasma | Cocaine SerPl-aCnc | null | DISCOURAGED | 1.0l | 2.73 |
16448-3 | Cocaine | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Cocaine [Units/volume] in Urine | Cocaine Ur-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
16449-1 | Benzthiazide | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Benzthiazide [Mass/volume] in Serum or Plasma | Benzthiazide SerPl-mCnc | null | ACTIVE | 1.0l | 2.42 |
16450-9 | Benzylhydrazine | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Benzylhydrazine [Mass/volume] in Serum or Plasma | Benzylhydrazine SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
1645-1 | Xylose^2H post 25 g xylose PO | MCnc | Pt | Bld | Qn | null | CHAL | 1 | Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO | Xylose 2h p 25 g Xyl PO Bld-mCnc | null | ACTIVE | 1.0 | 2.73 |
16451-7 | Beryllium | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Beryllium [Presence] in Urine | Beryllium Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16452-5 | Beta alanine | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Beta alanine [Presence] in Urine | B-Alanine Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16453-3 | Beta aminoisobutyrate | PrThr | Pt | Urine | Ord | null | CHEM | 1 | Beta aminoisobutyrate [Presence] in Urine | B-AIB Ur Ql | null | ACTIVE | 1.0l | 2.56 |
16454-1 | Beta galactosidase | CCnc | Pt | Bld | Qn | null | CHEM | 1 | Beta galactosidase [Enzymatic activity/volume] in Blood | B-Galactosidase Bld-cCnc | null | ACTIVE | 1.0l | 2.73 |
16455-8 | Beta hydroxybutyrate | SCnc | Pt | CSF | Qn | null | CHEM | 1 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid | B-OH-Butyr CSF-sCnc | null | ACTIVE | 1.0l | 2.34 |
16456-6 | Beta hydroxybutyrate | SCnc | Pt | Urine | Qn | null | CHEM | 1 | Beta hydroxybutyrate [Moles/volume] in Urine | B-OH-Butyr Ur-sCnc | null | ACTIVE | 1.0l | 2.73 |
16457-4 | Beta-N-acetylhexosaminidase.A | CCnc | Pt | WBC | Qn | null | CHEM | 1 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes | Hexosaminidase A WBC-cCnc | null | ACTIVE | 1.0l | 2.73 |
16458-2 | Bethanechol | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Bethanechol [Mass/volume] in Serum or Plasma | Bethanechol SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16459-0 | Bicarbonate | SCnc | Pt | Body fld | Qn | null | CHEM | 1 | Bicarbonate [Moles/volume] in Body fluid | HCO3 Fld-sCnc | null | ACTIVE | 1.0l | 2.34 |
16460-8 | Bicarbonate | SCnc | Pt | CSF | Qn | null | CHEM | 1 | Bicarbonate [Moles/volume] in Cerebral spinal fluid | HCO3 CSF-sCnc | null | ACTIVE | 1.0l | 2.34 |
16461-6 | Bicarbonate | SCnc | Pt | RBC | Qn | null | CHEM | 1 | Bicarbonate [Moles/volume] in Red Blood Cells | HCO3 RBC-sCnc | null | ACTIVE | 1.0l | 2.34 |
16462-4 | Bicarbonate | SCnc | Pt | Amnio fld | Qn | null | CHEM | 1 | Bicarbonate [Moles/volume] in Amniotic fluid | HCO3 Amn-sCnc | null | ACTIVE | 1.0l | 2.34 |
16463-2 | Bile acid.dihydroxy | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Bile acid.dihydroxy [Mass/volume] in Serum or Plasma | Di-OH Bile Ac SerPl-mCnc | null | ACTIVE | 1.0l | 2.67 |
16464-0 | Bile acid | ACnc | Pt | Exhl gas | Qn | null | CHEM | 1 | Bile acid [Units/volume] in Exhaled gas | Bile Ac ExG-aCnc | null | ACTIVE | 1.0l | 2.69 |
16465-7 | Bile acid | MCnc | Pt | Urine | Qn | null | CHEM | 1 | Bile acid [Mass/volume] in Urine | Bile Ac Ur-mCnc | null | ACTIVE | 1.0l | 2.73 |
16466-5 | Bile acid.trihydroxy | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Bile acid.trihydroxy [Mass/volume] in Serum or Plasma | Tri-OH Bile Ac SerPl-mCnc | null | ACTIVE | 1.0l | 2.67 |
16467-3 | Bismuth | PrThr | Pt | Bld | Ord | null | DRUG/TOX | 1 | Bismuth [Presence] in Blood | Bismuth Bld Ql | null | ACTIVE | 1.0l | 2.56 |
16468-1 | Bismuth | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Bismuth [Presence] in Urine | Bismuth Ur Ql | null | ACTIVE | 1.0l | 2.56 |
1646-9 | Xylose^post dose PO | MRat | 5H | Urine | Qn | null | CHAL | 1 | Xylose [Mass/time] in 5 hour Urine --post dose PO | Xylose p PO 5h Ur-mRate | null | ACTIVE | 1.0 | 2.73 |
16469-9 | Bismuth/Creatinine | MRto | Pt | Urine | Qn | null | DRUG/TOX | 1 | Bismuth/Creatinine [Mass Ratio] in Urine | Bismuth/Creat Ur | null | ACTIVE | 1.0l | 2.73 |
16470-7 | Blastomyces dermatitidis Ab | PrThr | Pt | Ser | Ord | Comp fix | MICRO | 1 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation | B dermat Ab Ser Ql CF | null | ACTIVE | 1.0l | 2.73 |
16471-5 | Blastomyces dermatitidis Ab | ACnc | Pt | Ser | Qn | null | MICRO | 1 | Blastomyces dermatitidis Ab [Units/volume] in Serum | B dermat Ab Ser-aCnc | null | ACTIVE | 1.0l | 2.73 |
16472-3 | Blastomyces dermatitidis rRNA | PrThr | Pt | Ser | Ord | Probe | MICRO | 1 | Blastomyces dermatitidis rRNA [Presence] in Serum by Probe | B dermat rRNA Ser Ql Probe | null | ACTIVE | 1.0l | 2.63 |
16473-1 | Bordetella parapertussis Ab | ACnc | Pt | Ser | Qn | null | MICRO | 1 | Bordetella parapertussis Ab [Units/volume] in Serum | B parapert Ab Ser-aCnc | null | ACTIVE | 1.0l | 2.69 |
16474-9 | Bordetella pertussis Ab | ACnc | Pt | Ser | Qn | Comp fix | MICRO | 1 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation | B pert Ab Ser CF-aCnc | null | ACTIVE | 1.0l | 2.69 |
16475-6 | Borrelia burgdorferi Ab | PrThr | Pt | CSF | Ord | IA | MICRO | 1 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay | B burgdor Ab CSF Ql IA | null | ACTIVE | 1.0l | 2.73 |
16476-4 | Borrelia burgdorferi Ab | PrThr | Pt | Body fld | Ord | IA | MICRO | 1 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay | B burgdor Ab Fld Ql IA | null | ACTIVE | 1.0l | 2.56 |
1647-7 | Tuberculosis reaction wheal^3D post 25 TU ID | Diam | Pt | Skin | Qn | null | CHALSKIN | 1 | Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal | TB Wheal 3D p 25 TU Diam | null | ACTIVE | 1.0 | 2.26 |
16477-2 | Borrelia burgdorferi Ab | PrThr | Pt | Body fld | Ord | null | MICRO | 1 | Borrelia burgdorferi Ab [Presence] in Body fluid | B burgdor Ab Fld Ql | null | ACTIVE | 1.0l | 2.56 |
16478-0 | Borrelia burgdorferi Ab.IgA | PrThr | Pt | Ser | Ord | IA | MICRO | 1 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay | B burgdor IgA Ser Ql IA | null | ACTIVE | 1.0l | 2.73 |
16479-8 | Borrelia burgdorferi Ab.IgA | PrThr | Pt | CSF | Ord | IA | MICRO | 1 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay | B burgdor IgA CSF Ql IA | null | ACTIVE | 1.0l | 2.56 |
16480-6 | Borrelia burgdorferi Ab.IgG | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | Borrelia burgdorferi IgG Ab [Presence] in Serum or Plasma by Immunoassay | B burgdor IgG SerPl Ql IA | null | ACTIVE | 1.0l | 2.73 |
16481-4 | Borrelia burgdorferi Ab.IgG | ACnc | Pt | Body fld | Qn | IA | MICRO | 1 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay | B burgdor IgG Fld IA-aCnc | null | ACTIVE | 1.0l | 2.73 |
16482-2 | Borrelia burgdorferi Ab.IgM | ACnc | Pt | Body fld | Qn | IA | MICRO | 1 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay | B burgdor IgM Fld IA-aCnc | null | ACTIVE | 1.0l | 2.73 |
16483-0 | Borrelia hermsii | PrThr | Pt | XXX | Ord | Organism specific culture | MICRO | 1 | Borrelia hermsii [Presence] in Specimen by Organism specific culture | B hermsii Spec Ql Cult | null | ACTIVE | 1.0l | 2.69 |
16484-8 | Boysenberry Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Boysenberry IgE Ab [Units/volume] in Serum | Boysenberrry IgE Qn | null | ACTIVE | 1.0l | 2.42 |
1648-5 | Tuberculosis reaction wheal^3D post 5 TU ID | Diam | Pt | Skin | Qn | null | CHALSKIN | 1 | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal | TB Wheal 3D p 5 TU Diam | null | ACTIVE | 1.0 | 2.73 |
16485-5 | Bromodiphenhydramine | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Bromodiphenhydramine [Mass/volume] in Urine | Bromodiphenhyd Ur-mCnc | null | ACTIVE | 1.0l | 2.42 |
16486-3 | Brucella abortus Ab.IgA+IgG+IgM | ACnc | Pt | Ser | Qn | null | MICRO | 1 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum | B abortus IgA+IgG+IgM Ser-aCnc | null | ACTIVE | 1.0l | 2.69 |
16487-1 | Brucella abortus Ab.IgG | ACnc | Pt | Ser | Qn | Aggl | MICRO | 1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination | B abortus IgG Ser Aggl-aCnc | null | ACTIVE | 1.0l | 2.73 |
16488-9 | Brucella abortus Ab.IgG | ACnc | Pt | Ser | Qn | Comp fix | MICRO | 1 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation | B abortus IgG Ser CF-aCnc | null | ACTIVE | 1.0l | 2.69 |
16489-7 | Brucella melitensis Ab | ACnc | Pt | Ser | Qn | LA | MICRO | 1 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination | B melitensis Ab Ser LA-aCnc | null | ACTIVE | 1.0l | 2.69 |
16490-5 | Brucella suis Ab | ACnc | Pt | Ser | Qn | LA | MICRO | 1 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination | B suis Ab Ser LA-aCnc | null | ACTIVE | 1.0l | 2.69 |
16491-3 | Brush border Ab | PrThr | Pt | Ser | Ord | IF | SERO | 1 | Brush border Ab [Presence] in Serum by Immunofluorescence | Brush border Ab Ser Ql IF | null | ACTIVE | 1.0l | 2.56 |
16492-1 | Bufotenine | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Bufotenine [Units/volume] in Urine | Bufotenine Ur-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
1649-3 | Calcitriol | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Calcitriol [Mass/volume] in Serum or Plasma | 1,25(OH)2D3 SerPl-mCnc | null | ACTIVE | 1.0 | 2.73 |
16493-9 | Bufotenine | ACnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Bufotenine [Units/volume] in Serum or Plasma | Bufotenine SerPl-aCnc | null | DISCOURAGED | 1.0l | 2.73 |
16494-7 | Bumetanide | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Bumetanide [Units/volume] in Urine | Bumetanide Ur-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
16495-4 | Buprenorphine | ACnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Buprenorphine [Units/volume] in Serum or Plasma | Buprenorphine SerPl-aCnc | null | DISCOURAGED | 1.0l | 2.73 |
16496-2 | Buprenorphine | ACnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Buprenorphine [Units/volume] in Urine | Buprenorphine Ur-aCnc | null | DISCOURAGED | 1.0l | 2.73 |
16497-0 | Butabarbital | MCnc | Pt | Gast fld | Qn | null | DRUG/TOX | 1 | Butabarbital [Mass/volume] in Gastric fluid | Butabarbital Gast-mCnc | null | ACTIVE | 1.0l | 2.42 |
16498-8 | Butalbital | ACnc | Pt | Gast fld | Qn | null | DRUG/TOX | 1 | Butalbital [Units/volume] in Gastric fluid | Butalbital Gast-aCnc | null | DISCOURAGED | 1.0l | 2.69 |
16499-6 | Butorphanol | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Butorphanol [Mass/volume] in Urine by Confirmatory method | Butorphanol Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16500-1 | Butyrate | MCnc | Pt | Stool | Qn | null | CHEM | 1 | Butyrate (C4) [Mass/volume] in Stool | Butyrate Stl-mCnc | null | ACTIVE | 1.0l | 2.34 |
1650-1 | 1,4-Alpha glucan branching enzyme | CCnc | Pt | WBC | Qn | null | CHEM | 1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes | GLGB WBC-cCnc | null | ACTIVE | 1.0 | 2.14 |
16501-9 | C peptide^7th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | C peptide sp7 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16502-7 | C peptide^8th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | C peptide sp8 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16503-5 | C reactive protein | MCnc | Pt | Body fld | Qn | null | CHEM | 1 | C reactive protein [Mass/volume] in Body fluid | CRP Fld-mCnc | null | ACTIVE | 1.0l | 2.73 |
16504-3 | Calcitonin^1.5M post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge | Calcit 1.5M p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16505-0 | Calcitonin^10M post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge | Calcit 10M p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16506-8 | Calcitonin^3H post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge | Calcit 3h p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16507-6 | Calcitonin^4H post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge | Calcit 4h p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16508-4 | Calcitonin^5M post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge | Calcit 5M p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16509-2 | Calcitonin^7th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge | Calcit sp7 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
165-1 | Cephapirin | Susc | Pt | Isolate | OrdQn | MIC | ABXBACT | 1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) | Cephapirin Islt MIC | null | ACTIVE | 1.0 | 2.19 |
16510-0 | Calcitonin^8th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge | Calcit sp8 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16511-8 | Calcitonin^9th specimen post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge | Calcit sp9 p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16512-6 | Calcium.ionized^2nd specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge | Ca-I sp2 p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16513-4 | Calcium.ionized^3rd specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge | Ca-I sp3 p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16514-2 | Calcium.ionized^4th specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge | Ca-I sp4 p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16515-9 | Calcium.ionized^5th specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge | Ca-I sp5 p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16516-7 | Calcium.ionized^6th specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge | Ca-I sp6 p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16517-5 | Calcium.ionized^7th specimen post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge | Ca-I sp7 p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16518-3 | Calcium | MRat | 2H | Urine | Qn | null | CHEM | 1 | Calcium [Mass/time] in 2 hour Urine | Calcium 2h Ur-mRate | null | ACTIVE | 1.0l | 2.73 |
1651-9 | 1-Methylhistidine | PrThr | Pt | Ser/Plas | Ord | null | CHEM | 1 | 1-Methylhistidine [Presence] in Serum or Plasma | 1Me-hist SerPl Ql | null | ACTIVE | 1.0 | 2.56 |
16519-1 | Calcium^10M post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge | Calcium 10M p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16520-9 | Calcium^2nd specimen post XXX challenge | SCnc | Pt | Urine | Qn | null | CHAL | 1 | Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge | Calcium sp2 p chal Ur-sCnc | null | ACTIVE | 1.0l | 2.34 |
16521-7 | Calcium^3rd specimen post XXX challenge | SCnc | Pt | Urine | Qn | null | CHAL | 1 | Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge | Calcium sp3 p chal Ur-sCnc | null | ACTIVE | 1.0l | 2.34 |
16522-5 | Calcium^4th specimen post XXX challenge | SCnc | Pt | Urine | Qn | null | CHAL | 1 | Calcium [Moles/volume] in Urine --4th specimen post XXX challenge | Calcium sp4 p chal Ur-sCnc | null | ACTIVE | 1.0l | 2.34 |
16523-3 | Calcium^5M post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge | Calcium 5M p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16524-1 | Calcium^6H post XXX challenge | SCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge | Calcium 6h p chal SerPl-sCnc | null | ACTIVE | 1.0l | 2.34 |
16525-8 | Calcium/Phosphate | MRto | Pt | Ser/Plas | Qn | null | CHEM | 1 | Calcium/Phosphate [Mass Ratio] in Serum or Plasma | Calcium/Phosphate SerPl | null | ACTIVE | 1.0l | 2.73 |
16526-6 | Calcium/Protein | MRto | Pt | Ser/Plas | Qn | null | CHEM | 1 | Calcium/Protein [Mass Ratio] in Serum or Plasma | Calcium/Prot SerPl | null | ACTIVE | 1.0l | 2.42 |
1652-7 | 1-Methylhistidine | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 1-Methylhistidine [Mass/volume] in Serum or Plasma | 1Me-hist SerPl-mCnc | null | ACTIVE | 1.0 | 2.73 |
16527-4 | Calcium/Sodium | MRto | Pt | Ser/Plas | Qn | null | CHEM | 1 | Calcium/Sodium [Mass Ratio] in Serum or Plasma | Calcium/Sodium SerPl | null | ACTIVE | 1.0l | 2.42 |
16528-2 | Campylobacter coli rRNA | ACnc | Pt | Ser | Qn | Probe | MICRO | 1 | Campylobacter coli rRNA [Units/volume] in Serum by Probe | C coli rRNA Ser Probe-aCnc | null | ACTIVE | 1.0l | 2.69 |
16529-0 | Campylobacter jejuni rRNA | ACnc | Pt | Ser | Qn | Probe | MICRO | 1 | Campylobacter jejuni rRNA [Units/volume] in Serum by Probe | C jejuni rRNA Ser Probe-aCnc | null | ACTIVE | 1.0l | 2.69 |
16530-8 | Campylobacter jejuni rRNA | PrThr | Pt | Ser | Ord | Probe | MICRO | 1 | Campylobacter jejuni rRNA [Presence] in Serum by Probe | C jejuni rRNA Ser Ql Probe | null | ACTIVE | 1.0l | 2.63 |
16531-6 | Campylobacter lari rRNA | ACnc | Pt | Ser | Qn | Probe | MICRO | 1 | Campylobacter lari rRNA [Units/volume] in Serum by Probe | C lari rRNA Ser Probe-aCnc | null | ACTIVE | 1.0l | 2.69 |
16532-4 | Campylobacter lari rRNA | PrThr | Pt | Ser | Ord | Probe | MICRO | 1 | Campylobacter lari rRNA [Presence] in Serum by Probe | C lari rRNA Ser Ql Probe | null | ACTIVE | 1.0l | 2.63 |
16533-2 | Helicobacter pylori Ab | Titr | Pt | Ser | Qn | null | MICRO | 1 | Helicobacter pylori Ab [Titer] in Serum | H pylori Ab Titr Ser | null | ACTIVE | 1.0l | 2.70 |
16534-0 | Campylobacter sp rRNA | PrThr | Pt | Ser | Ord | Probe | MICRO | 1 | Campylobacter sp rRNA [Presence] in Serum by Probe | Campylobacter rRNA Ser Ql Probe | null | ACTIVE | 1.0l | 2.63 |
1653-5 | 1-Methylhistidine | MCnc | Pt | Urine | Qn | null | CHEM | 1 | 1-Methylhistidine [Mass/volume] in Urine | 1Me-hist Ur-mCnc | null | ACTIVE | 1.0 | 2.42 |
16535-7 | Canary droppings Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Canary droppings IgE Ab [Units/volume] in Serum | Canary Drop IgE Qn | null | ACTIVE | 1.0l | 2.42 |
16536-5 | Canary serum proteins Ab | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Canary serum proteins Ab [Units/volume] in Serum | Canary Serum Prot Ab Qn | null | ACTIVE | 1.0l | 2.69 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.